This sample shows 100 sentences.
The full EPAR for Improvac can be found on the Agency 's website : ema.europa.eu / Find medicine / Veterinary medicines / European public assessment reports .
ema.europa.eu / Find medicine / Veterinary medicines / European public assessment reports .
This summary was last updated in September 2017 .
Dan is - sommarju ġie aġġornat l - aħħar f'Settembru 2017 .
EPAR summary for the public
Sommarju tal - EPAR għall - pubbliku
The most common side effects with Improvac ( which may affect more than 1 in 10 pigs ) are injection site swelling , which gradually resolves but in 20 to 30 % of animals will last for more than 6 weeks , and a short-lived increase in body temperature of around 0.5 ˚ C within 24 hours of vaccination .
L - effetti sekondarji l - aktar komuni b'Improvac ( li jistgħu jaffettwaw aktar minn 1 minn kull 10 ħnieżer ) huma nefħa fis - sit tal - injezzjoni , li titlaq gradwalment iżda f ' 20 sa 30 % tal - annimali ddum għal aktar minn 6 ġimgħat , u żieda fit - temperatura tal - ġisem li ma ddumx ta ' madwar 0.5 ˚ C fi żmien 24 siegħa mit - tilqim .
The European Commission granted a marketing authorisation valid throughout the EU for Improvac on 11 May 2009 .
Il - Kummissjoni Ewropea tat awtorizzazzjoni għat - tqegħid fis - suq valida fl - UE kollha għal Improvac fil - 11 ta ' Mejju 2009 .
Other information about Improvac ?
Informazzjoni oħra dwar Improvac ?
This is a summary of the European public assessment report ( EPAR ) for Improvac .
Dan huwa sommarju tar - rapport pubbliku Ewropew ta ' valutazzjoni ( EPAR ) għal Improvac .
What are the risks associated with Improvac ?
X'inhuma r - riskji assoċjati ma ' Improvac ?
The first injection is from 8 weeks of age and the second 4 to 6 weeks before slaughter .
L - ewwel injezzjoni hija mill - età ta ' 8 ġimgħat u t - tieni 4 sa 6 ġimgħat qabel il - qtil .
The active substance in Improvac is an analogue of ( similar to ) gonatadotropin releasing factor ( GnRF ) linked to a carrier protein obtained from the bacterium Corynebacterium diphtheriae .
Is - sustanza attiva f'Improvac hija analogu ta ' ( simili għal ) fattur li jirrilaxxa l - gonatadotropin ( GnRF ) marbut ma ' proteina ġarriera miksuba mill - batterju Corynebacterium diphtheriae .